ITGAE and neoplasm: Side-by-side comparison of large endpoint Y3.3UVRc34 and YR1.7 tumors identified thirteen immune infiltrating subsets with a myeloid prevalence in both models, including tumor-associated macrophages (TAM), MHC-II− and MHC-II+ monocyte subsets, granulocytes (significantly enriched in YR1.7 model), myeloid-derived suppressor cells (MDSC) and three populations of dendritic cells (DCs) including plasmacytoid DCs (pDCs), conventional CD103+ DCs (cDC1) and conventional CD11b+ DCs (cDC2) (Figure 3a and Figure S3a).